secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2026-07-02T20:21:14+00:00
Accession:  0001193125-26-294619
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.08, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences discloses $169K discretionary bonus to CEO Schaefer for 2025; sets 2026 annual meeting for Sept 10
--------------------------------------------------------------------------------

- CEO Thomas Schaefer received $169,000 discretionary cash bonus for 2025; no other NEOs received bonus.
- Schaefer's total 2025 compensation: $473,058 (salary $260K, bonus $169K, option awards $40K, other $4K).
- 2026 annual meeting set for September 10, 2026; stockholder proposals due by July 13, 2026.
- Company did not pay bonuses under Executive Incentive Bonus Plan for 2025 due to terminated business combination transaction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000119312526294619/0001193125-26-294619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000119312526294619/rkda-20260701.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-294619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer